Background {#Sec1}
==========

Influenza virus causes an acute contagious respiratory tract infection, which is a major contributor to morbidity and mortality among human population. Historically pandemic flu has caused widespread human deaths, most notably the 1918 "Spanish Flu" (A/H1N1) which killed 25--50 million people worldwide \[[@CR1]\]. Novel swine-origin influenza A (H1N1 subtype) virus identified in Mexico in 2009 emerges to spread rapidly worldwide via human-human transmission \[[@CR2]\] and led to at least 17,798 deaths in 214 countries. Therefore, pandemic influenza A viruses such as the H1N1subtype becomes a serious global public health problem, which calls for more agents of anti-influenza therapies as possible.

Neuraminidase (NA) is an antigenic glycoprotein on the surface of influenza virus, which takes charge of catalyzing the cleavage of neuraminic acid residues to facilitate the detachment from the host cell surface at the end of the viral replication cycle and suppresses their self-aggregation of the virions \[[@CR3], [@CR4]\]. NA plays a critical role for virus replication and spread in infected tissues during infection, and has been well established as a primary drug target for anti-influenza therapies \[[@CR5], [@CR6]\]. Some potent NA inhibitors, including oseltamivir, zanamivir, laninamivir and peramivir, have been designed and applied in clinical treatments \[[@CR7], [@CR8]\]. Unfortunately, resistance to these NA inhibitors has been extensively reported \[[@CR9]--[@CR11]\]. Therefore, there is a continuing need for developing novel NA inhibitors as anti-influenza agents. Medicinal plants may be a probable source for the discovery of natural NA inhibitors and might provide leads to develop the NA inhibitors \[[@CR12]\].

In order to search for novel anti-influenza agents from natural resources, a library of 190 extracts of 95 medicinal plants traditionally used in Lingnan Chinese Medicines were screened for in vitro inhibitory activity against A (H1N1) influenza virus neuraminidase using high-throughput assay. The most active five extracts (**1**--**5**) were selected to further study their action upon the replication of influenza viruses using cytopathic effect (CPE) reduction assay and quantitative RT-PCR analysis. The results showed that these herbal extracts significantly inhibited the NA activity and the replication of influenza viruses, and exhibited very low cytotoxicity to the host cells.

Methods {#Sec2}
=======

Plant materials {#Sec3}
---------------

Ninety nine medicinal plants traditionally used in Lingnan Chinese Medicines were collected in Guangzhou in 2009. The identity of the plants samples was verified by Dr. Guangtian Peng (Guangzhou University of Chinese Medicine). Voucher specimens of these materials were deposited for references in the Research Center of Medicinal Plants Resource Science and Engineering, Guangzhou University of Chinese Medicine. The samples were stored in the shade at room temperature and pulverized before use.

Standard extraction preparation {#Sec4}
-------------------------------

Dried powdered plants (100 g) were extracted with ethyl acetate (EtOAc, 250 mL × 3) and methanol (MeOH, 250 mL × 3) by ultrasound wave at 40 kHz and 400 W at 45 °C for 30 min, the filtrates were evaporated under vacuum at 45 °C to give the EtOAc and MeOH extracts, respectively. A total of 190 herbal extracts were obtained. A stock solution for each extract was prepared by dissolution to dimethyl sulfoxide (DMSO), 50 mg of each extract was suspended in 1 ml of DMSO ensuing stock concentration of 50 μg/μL. The solutions were filtered by using 0.22 μm filters, and stored at − 20 °C. The concentration of DMSO in test dilutions was restricted to no more than 0.5% (*v*/v) to minimize potential effects of the solvent on enzyme activity and cell growth.

Neuraminidase, virus and cells {#Sec5}
------------------------------

The human influenza virus strains A/PR/8/34 (H1N1) was kindly provided by China Centers for Disease Control, and was used as the source of NA; Madin-Darby canine kidney (MDCK) and A549 cell lines were obtained from the National Center for Pharmaceutical Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences. Madin-Darby canine kidney (MDCK) cells were grown in Dulbecco's modified Eagle medium (DMEM) containing 10% fetal bovine serum (FBS) at 37 °C and 5% CO~2~ atmosphere. MDCK cells were used for virus infection, and were washed with PBS buffer before infection. 2′-(4-methylunbelliferyl)-*α-D*-acetyl-neuraminic acid (MUNANA), 2-(N-Morpholino)-ethanesulfonic acid (MES) and 3-\[4,5-dimethyl-thiazol-2-yl\]-2,5-diphenyl tetrazolium bromide (MTT) were purchased from Sigma. DMEM, FBS, and 0.25% trypsin-EDTA were purchased from Gibco. Ribavirin with purity more than 98%, and zanamivir with purity more than 98% were purchased from Sigma (Lot\#020 M4003) and Full Land international trade company in Shanghai of China (Lot\#091209-005LY), respectively. They were used as references in NA and CPE inhibition assays.

In vitro screening of plant extracts for NA activity {#Sec6}
----------------------------------------------------

Inhibition of influenza virus NA activity was determined by a standard fluorimetric method \[[@CR13], [@CR14]\] using4-methylumbelliferyl-α-D-N-acetyl-neuraminate (MUNANA) (Sigma) as substrate, in 96-well microplates. The reaction mixture containing the extracts or compounds, and NA enzyme in MES buffer (32.5 mM) and calcium chloride (4 mM, pH 6.5) was incubated for 60 min. After incubation, the reaction was terminated by adding NaOH (34 mM). Fluorescence intensity (M) was quantified with excitation wavelength at 360 nm and emission wavelength at 450 nm. Percentage inhibition was calculated relative to a blank reaction mixture (solvent control) containing virus NA and solvent (% Inhibition = \[1-(M~extract~/M~control~)\] × 100). The 50% inhibitory concentration (IC~50~) was defined as the concentration of NA inhibitor necessary to reduce NA activity by 50% relative to a blank reaction mixture. IC~50~ values displayed represent the mean of three individual determinations each performed in triplicate assays. Zanamivir (Sigma) was used as the reference compound.

Cytotoxicity assay {#Sec7}
------------------

The cytotoxicity of medicinal plant extracts was determined with the MTT (Sigma) method as described previously \[[@CR15]\]. Briefly, different concentrations of the extracts and compounds were added to each well of a 96-well culture plate containing a confluent cell monolayer in triplicate, blank medium was used as the control. After incubation at 37 °C in an atmosphere of 5% CO~2~ for 72 h, 12 μL of MTT solution (5 mg/ml in phosphate buffered saline) was added to each well. The plate was further incubated at 37 °C for 3 h to allow formation of formazan product. After removing the medium, 100 μL of DMSO was added to dissolve the formazan crystals. After 15 min, the contents of the wells were homogenized on a microplate shaker. The optical densities (OD) were then determined by measuring absorbance with a microplate spectrophotometer at a wavelength of 540 nm and a reference wavelength of 620 nm. The median cytotoxic concentration (CC~50~) was calculated as the concentration of the constituent that reduced the viable cells to 50% of the untreated control. The maximal non-cytotoxic concentration (MNCC) was defined as the maximal concentration of the sample that did not exert a cytotoxic effect and resulted in more than 90% viable cells.

CPE reduction assay {#Sec8}
-------------------

The anti-viral activity of the extracts was measured by a virus-induced cytopathic effect (CPE) reduction assay as described previously \[[@CR14], [@CR16]\]. Briefly, 100 μL of virus suspension of 200 tissue culture infective dose (TCID~50~/mL) was added to each well of a 96-well culture plate containing confluent a MDCK cells monolayer. After incubation at 37 °C for 2 h, the virus solution was removed, and 100 μL of serial dilutions of the extracts and ribavirin were added to each well of the 96-well culture plates, using the maximal non-cytotoxic concentration (MNCC) as the highest concentration. The plates were incubated at 37 °C in a humidified 5% CO~2~ atmosphere for 48 h, and then the CPE was assessed. The virus-induced CPE was scored as follows: 0 = no CPE, 1 = 0--25% CPE, 2 = 25%--50% CPE, 3 = 50%--75% CPE, and 4 = 75%--100% CPE. Apart from test group, there were control group (treated with FBS-free medium instead of extracts and virus) and model group (treated with FBS-free medium and virus instead of extracts and virus). The CPE inhibition ratios were calculated using the equation: CPE inhibition % = 100 -\[(OD~test~-OD~control~) \*100/ (OD~model~- OD~control~)\]. The OD~test~, OD~model~, and OD~control~ mean the optical density of test group, model group, and control group, respectively. At least three independent experiments with three parallel experiments were performed to determine the mean and SD value.

Measurement of viral RNA synthesis by quantitative and reverse transcription PCR (qPCR) {#Sec9}
---------------------------------------------------------------------------------------

A549 cells were grown in RPMI1640 to about 90% confluence and were infected with influenza virus A/PR/8/34 (H1N1) influenza virus at 100 TCID~50~, followed by administration of test extracts for 5 h. To determine the expression level of hemagglutinin (HA) gene mRNA of influenza virus, cells were harvested and the total RNA was extracted by TRIzol (Invitrogen) according to the manufacture's instruction. The primer sequences which were designed by Primer-BLAST from NCBI for quantitative real-time PCR of influenza virus were 5'-CCTGCTCGAAGACAGCCACAACG-3′ (sense) and 5'-TTCCCAAGAGCCATCCGGCGA-3′ (antisense). The GAPDH were used as internal control of cellular RNAs, with primer sequence of 5′- TGCTCCGAAGGGTGGCCCTTA-3′(sense) and 5′- TGCGTGTTTCCAGAGCCGTGC-3′(antisense). The total RNA was reverse transcribed into cDNA using the TransScript First-Strand cDNA Synthesis SuperMix (TransGen Biotech, Beijing, China). The cDNA was used as template for real-time PCR conducted by SsoFast EvaGreen PCR 2 × master mix (Bio-Rad) using CFX 96 Realtime PCR system (Bio Rad location) according to the manufacture's protocol. The data was analyzed using the mode for normalised expression (2^-ΔΔCq^).

Statistical analysis {#Sec10}
--------------------

Statistical analysis was performed using the Student's unpaired t-test. The results were presented as mean ± S.D. (*n* = 3). ^\*^*p* \< 0.05 and ^\*\*^*p* \< 0.001 indicate a statistically significant difference as compared to the untreated control.

Results {#Sec11}
=======

NA has been validated as one of the most important targets to screen the drugs of anti-influenza virus. We first examined the ability of 190 organic extracts from 95 medicinal plants to inhibit NA activity by in vitro screening assay. Zanamivir was used as a positive control, its IC~50~ value to NA inhibition was 0.05 μg/mL. 14 extracts were found to effectively inhibit the NA activity at the concentration of 40 μg/mL. Among them, 5 extracts exhibited potent inhibition of NA activity, 9 extracts exhibited moderate NA inhibitory activity with IC~50~ values ranged from 4.1 to 37.3 μg/mL. The bioactive extracts and their NA inhibition activity were summarized in Table [1](#Tab1){ref-type="table"}. The highest activity was demonstrated by MeOH extracts of *Melaphis chinensis* (**1**) and *Amomurn villosum* Lour (**2**) with IC~50~ = 4.1 and 4.9 μg/mL, respectively. Significant activity with IC~50~ = 5.0--10 μg/mL was also shown by MeOH extract of *Sanguisorba officinalis* (**3**), EtOAc extract of *Melaphis chinensis* (**4**) and MeOH extract of *Flos Caryophylli* (**5**). While other plant extracts (**6**--**14**) showed a moderate inhibitory activity on NA with the IC~50~ values ranging from 20.3 to 37.3 μg/mL. These results demonstrated that these plant extracts possessed significant inhibitory activities against influenza virus NA and the most active extracts **1**--**5** were then selected to further study their effects on the replication of influenza virus.Table 1Inhibitory activities of Chinese herbs extract on A(H1N1) influenza virus neuraminidaseNo.Positive control and Botanical nameBotanical partExtractInhibition (%)^a^IC~50~^b^Voucher No.--Zanamivir----99.80.05--1*Melaphis chinensis* (Bell)BakercecidiumMeOH103.64.1MCB0911012*Amomurn villosum* Lour.fruitMeOH92.24.9CG200808293*Sanguisorba officinalis L.*rootMeOH100.85.1SOL0911014*Melaphis chinensis (Bell)Baker*cecidiumEtOAc99.35.3MCB0911015*Flos Caryophylli*flowersMeOH94.19.1SA0911016*Areca catechu Linn*fruitMeOH85.119.3ACL0911017*Artemisia capillaries Thunb*whole plantMeOH91.319.4ACT0911018*Terminalia chebula Retz*fruitEtOAc78.420.3TCR0911019*Duchesnea indica (Andr.) Focke*whole plantEtOAc69.123.3DIF09110110*Terminalia chebula Retz.*fruitMeOH6824.3TCR09110110*Murraya exotica L.*stem and leavesMeOH65.728.9MEL09110111*Geranium carolinianum L.*whole plantMeOH64.828.9GCL09110112*Polygonum cuspidatum*rhizomeEtOAc63.929.8PC09110113*Saposhnikovia divaricata (Turez.) Schischk.*rootEtOAc53.137.3SDS09110114*Callicarpa formosana Rolfe*fruitMeOH47.9NT^d^CFR09110315*Gardenia jasminoides Ellis*fruitMeOH46.6NTGJE09110116*Duchesnea indica (Andr.) Focke*whole plantEtOAc46.1NTDIF09110117*Rosa laevigata Michx.*stem and leavesEtOAc45.8NTRLM09110318*Euphorbia humifusa Willd. ex Schlecht.*whole plantMeOH43.9NTEHW09110119*Litchi chinensis Sonn.*seedEtOAc43.9NTLCS09110120*Punica granatum L.*fruit peelMeOH43.4NTPGL09110121*Scutellaria baicalensis Georgi*rootEtOAc41.3NTSBG09110122*Amomum villosum Lour.*fruitEtOAc40.5NTCG2008082923*Geranium carolinianum L.*whole plantEtOAc40.1NTGCL09110124*Isatis indigotica Fort*stem and leavesEtOAc40.1NTIIF09110325*Onosma gmelinii Ledeb*rootEtOAc40NTOGL09110126*Houttuynia cordata Thunb*whole plantEtOAc38.5NTHCT09110127*Altingia chinensis (Champ.) Oliver ex Hance*stem and leavesEtOAc37.3NTACO09110328*Pogostemon cablin (Blanco) Bent.*whole plantEtOAc36.7NTPCB09110129*Polygonum cuspidatum*rhizomeMeOH36.1NTPC09110130*Punica granatum L.*fruit peelEtOAc35.5NTPGL09110131*Rosa laevigata Michx.*stem and leavesMeOH34.4NTRLM09110332*Dianella ensifolia (Linn.) Redouté*fruitEtOAc31.5NTDER09110333*Elsholtzia ciliata (Thunb.) Hyland.*whole plantMeOH31.3NTECH09110134*Atractylodes Lancea (Thunb) DC.*rootEtOAc30.4NTALD09110135*Cynanchum otophyllum Schneid.*rootEtOAc29.3NTCOS09110136*Homalocladium platycladum (F. Muell.) Bailey*whole plantMeOH29.1NTHPB09110137*Cinnamomum cassia Presl*branchMeOH28.9NTCCP09110138*Elsholtzia ciliata (Thunb.) Hyland.*whole plantEtOAc28.1NTECP09110139*Sarcandra glabra (Thunb.) Nakai*stem and leavesEtOAc26.8NTSGN09110340*Altingia chinensis (Champ.) Oliver ex Hance*stem and leavesMeOH25.8NTACO09110341*Litchi chinensis Sonn.*seedMeOH25.5NTLCS09110142*Phellodendron chinense Schneid*barkEtOAC25.4NTPCS09110143*Euphorbia humifusa Willd. ex Schlecht.*whole plantEtOAc23.6NTEHW09110144*Glycyrrhiza uralensis Fisch.*rhizomeEtOAc23.1NTGUF09110145*Woodwardia japonica (L. f.) Sm.*rhizomeMeOH23NTWJS09110146*Ardisia japonica (Thunb) Blume*whole plantMeOH22.7NTAJB09110147*Cinnamomum cassia Presl*branchEtOAc22.7NTCCP09110148*Equisetum hyemale L.*whole plantEtOAc22.1NTEHL09110149*Fraxinus rhynchophylla Hance*barkEtOAc22.1NTFRH09110150*Ardisia japonica (Thunb.) Blume*whole plantEtOAc21.7NTAJB09110151*Andrographis paniculata (Burm. f.) Nees*whole plantEtOAc20.8NTAPN09110152*Punica granatum Linn.*stemEtOAc20.2NTAGL09110353*Syzygium aromaticum*flowersEtOAc19.5NTSA09110154*Artemisia capillaris Thunb.*whole plantEtOAc19.2NTACT09110155*Nepeta cataria L.*whole plantMeOH18.9NTNCL09110156*Lonicera japonica Thunb.*flowersMeOH18NTAJT09110157*Woodwardia japonica (L. f.) Sm.*rhizomeEtOAc17.9NTWJS09110158*Nepeta cataria L.*whole plantEtOAc17.4NTNCL09110159*Dendranthema indicum (L.) Des Moul.*flowersEtOAc16.5NTDID09110160*Senecio scandens Buch. -Ham. ex D. Don*whole plantMeOH16.3NTSSB09110161*Onosma gmelinii Ledeb*rootMeOH15.9NTOGL09110162*Evodia rutaecarpa (Juss.) Benth.*fruitMeOH15.5NTERB09110163*Ligusticum chuanxiong Hort.*rootMeOH15.5NTLCH09110164*Atractylodes Lancea (Thunb.) DC.*rootMeOH15.2NTALD09110165*Punica granatum L.*leavesMeOH15NTPGL09110166*Artemisia indices Willd.*leavesMeOH14.8NTAIW09110167*Serissa japonica (Thunb.) Thunb.*stem and leavesEtOAc14.8NTSJT09110168*Prunella vulgaris L.*whole plantMeOH14.1NTPVL09110169*Dicliptera chinensis (L.) Juss.*whole plantMeOH14NTDCJ09110170*Glycyrrhiza uralensis Fisch.*rhizomeMeOH13.7NTGUF09110171*Platycladus orientalis (L.) Franco*leavesEtOAc13.4NTPOF09110172*Angelica dahurica (Fisch. ex Hoffm.) Benth.*rootMeOH13.3NTADB09110173*Sarcandra glabra (Thunb.) Nakai*stem and leavesMeOH13.3NTSGN09110174*Cynanchum otophyllum Schneid.*rootMeOH13NTCOS09110175*Clerodendrum fortunatum Linn.*stem and leavesEtOAc12.5NTCFL09110176*Scutellaria baicalensis Georgi*rootMeOH12.2NTSBG09110177*Sophora flavescens Alt.*rootMeOH11.6NTSFA09110178*Paris verticillata M.Bieb.*rhizomeEtOAc11.4NTPVM09110179*Semiaquilegia adoxoides (DC.) Makino*whole plantEtOAc11.4NTSAM09110180*Magnolia liliflora Desr.*flowersEtOAc11.3NTMLD09110181*Albizia julibrissin Durazz.*flowersMeOHNA^c^NTAJD09110182*Albizia julibrissin Durazz.*flowersEtOAcNANTAJD09110183*Andrographis paniculata (Burm. f.) Nees*whole plantMeOHNANTAPN09110184*Angelica dahurica (Fisch. ex Hoffm.) Benth.*rootEtOAcNANTADB09110185*Arctium lappa L.*seedMeOHNANTALL09110186*Arctium lappa L.*seedEtOAcNANTALL09110187*Areca catechu Linn*fruitEtOAcNANTACL09110188*Artemisia argyi Levl. et Van.*leavesMeOHNANTAAL09110189*Artemisia argyi Levl. et Van.*leavesEtOAcNANTAAL09110190*Artemisia carvifolia Buch. -Ham. ex Roxb.*whole plantEtOAcNANTACB09110191*Artemisia carvifolia Buch. -Ham. ex Roxb.*whole plantMeOHNANTACB09110192*Artemisia indices Willd.*leavesEtOAcNANTAIW09110393*Bidens pilosa Linn.*whole plantEtOAcNANTBPL09110394*Bidens pilosa Linn.*whole plantMeOHNANTBPL09110395*Bupleurum tenue Buch-Ham. ex D. Don*rootEtOAcNANTBTB09110196*Bupleurum tenue Buch-Ham. ex D. Don*rootMeOHNANTBTB09110197*Callicarpa formosana Rolfe*fruitEtOAcNANTCFR09110398*Clerodendrum fortunatum Linn.*stem and leavesMeOHNANTCFL09110399*Clinopodium megalanthum*seedEtOAcNANTCMC091101100*Clinopodium megalanthum*seedMeOHNANTCMC091101101*Crataegus pinnatifida Bge.*fruitMeOHNANTCPB091101102*Crataegus pinnatifida Bge.*fruitEtOAcNANTCPB091101103*Dendranthema indicum (L.) Des Moul.*flowersMeOHNANTDID091101104*Dendranthema morifolium (Ramat.) Tzvel.*flowersEtOAcNANTDMT091101105*Dendranthema morifolium (Ramat.) Tzvel.*flowersMeOHNANTDMT091101106*Dianella ensifolia (Linn.) Redouté*fruitMeOHNANTDER091103107*Dicliptera chinensis (L.) Juss.*whole plantEtOAcNANTDCJ091103108*Duchesnea indica (Andr.) Focke*whole plantMeOHNANTDIF091103109*Epaltes australis Less.*whole plantEtOAcNANTEAL091101110*Epaltes australis Less.*whole plantMeOHNANTEAL091101111*Equisetum hyemale L.*whole plantMeOHNANTEHL091101112*Euchresta japonica Hook. f. ex Regel*rootEtOAcNANTEJH091101113*Euchresta japonica Hook. f. ex Regel*rootMeOHNANTEJH091101114*Eupatorium catarium Veldkamp*whole plantMeOHNANTECV091103115*Eupatorium catarium Veldkamp*whole plantEtOAcNANTECV091103116*Eupatorium fortunei Turcz.*whole plantEtOAcNANTEFT091101117*Eupatorium fortunei Turcz.*whole plantMeOHNANTEFT091101118*Eupolyphaga seu Steleophaga*insectEtOAcNANTESS091101119*Eupolyphaga seu Steleophaga*insectMeOHNANTESS091101120*Evodia rutaecarpa (Juss.) Benth.*fruitEtOAcNANTERB091101121*Ficus hirta Vahl*leavesMeOHNANTFHV091101122*Ficus hirta Vahl*leavesEtOAcNANTFHV091101123*Forsythia suspensa (Thunb.) Vahl*fruitMeOHNANTFSV091101124*Forsythia suspensa (Thunb.) Vahl*fruitEtOAcNANTFSV091101125*Fraxinus rhynchophylla Hance*barkMeOHNANTFRH091101126*Gardenia jasminoides Ellis*fruitEtOAcNANTGJE091101127*Homalocladium platycladum (F. Muell.) Bailey*whole plantEtOAcNANTHPB091103128*Homalomena occulta (Lour.) Schot*rhizomeMeOHNANTHOS091101129*Homalomena occulta (Lour.) Schot*rhizomeEtOAcNANTHOS091101130*Houttuynia cordata Thunb*whole plantMeOHNANTHCT091101131*Ilex cornuta Lindl*stemMeOHNANTICL091103132*Ilex cornuta Lindl*stemEtOAcNANTICL091103133*Inula japonica Thunb.*flowersMeOHNANTIJT091101134*Inula japonica Thunb.*flowersEtOAcNANTIJT091101135*Isatis indigotica Fort*stem and leavesMeOHNANTIIF091103136*Ligusticum chuanxiong Hort.*rootEtOAcNANTLCH091101137*Lobelia chinensis Lour.*whole plantMeOHNANTLCH091101138*Lobelia chinensis Lour.*whole plantEtOAcNANTLCL091101139*Lonicera confusa (Sweet) DC.*stem and leavesMeOHNANTLCD091103140*Lonicera confusa (Sweet) DC.*stem and leavesEtOAcNANTLCD091103141*Lonicera japonica Thunb.*flowersEtOAcNANTLJT091101142*Lonicera japonica Thunb.*stem and branchMeOHNANTLJT091101143*Lonicera japonica Thunb.*stem and branchEtOAcNANTLJT091101144*Lycium chinense Mill.*root barkMeOHNANTLCM091101145*Lycium chinense Mill.*Root barkEtOAcNANTLCM091101146*Magnolia liliflora Desr.*flowersMeOHNANTMLD091101147*Melia azedarach L.*barkEtOAcNANTMAL091103148*Melia azedarach L.*barkMeOHNANTMAL091103149*Murraya exotica L.*stem and leavesEtOAcNANTMEL091103150*Mussaenda pubescens Ait. f.*stem and leavesEtOAcNANTMPA091103151*Mussaenda pubescens Ait. f.*stem and leavesMeOHNANTMPA091103152*Paris verticillata M.Bieb.*rhizomeMeOHNANTPVM091101153*Perilla frutescens (L.) Britt.*flowersEtOAcNANTPFB091103154*Perilla frutescens (L.) Britt.*flowersMeOHNANTPFB091103155*Peucedanum praeruptorum Dunn*rootEtOAcNANTPPD091101156*Peucedanum praeruptorum Dunn*rootMeOHNANTPPD091101157*Phellodendron chinense Schneid*barkMeOHNANTPCS091101158*Phytolacca acinosa Roxb.*rootEtOAcNANTPAR091101159*Phytolacca acinosa Roxb.*rootMeOHNANTPAR091101160*Pinellia ternata (Thunb.) Breit.*stemMeOHNANTPTB091101161*Pinellia ternata (Thunb.) Breit.*stemEtOAcNANTPTB091101162*Platycladus orientalis (L.) Franco*leavesMeOHNANTPOF091101163*Pogostemon cablin (Blanco) Bent.*whole plantMeOHNANTPCB091101164*Prunella vulgaris L.*whole plantEtOAcNANTPVL091101165*Punica granatum L.*leavesEtOAcNANTPGL091103166*Punica granatum Linn.*stemMeOHNANTPGL091103167*Sanguisorba officinalis L.*rootEtOAcNANTSOL091101168*Saposhnikovia divaricata (Trucz.) Schischk.*rootMeOHNANTSDS091101169*Scaphium wallichii Shott & Endl.*seedMeOHNANTSWS091101170*Scaphium wallichii Shott & Endl.*seedEtOAcNANTSWS091101171*Semiaquilegia adoxoides (DC.) Makino*whole plantMeOHNANTSAM091101172*Senecio scandens Buch-Ham. ex D. Don*whole plantEtOAcNANTSSB091101173*Serissa japonica (Thunb.) Thunb.*stem and leavesMeOHNANTSJT091103174*Sophora flavescens Alt.*rootEtOAcNANTSFA091101175*Stemona japonica (Bl.) Miq.*rootMeOHNANTSJM091101176*Stemona japonica (Bl.) Miq.*rootEtOAcNANTSJM091101177*Strobilanthes cusia (Ness) W. Ktze.*stem and leavesMeOHNANTSCW091101178*Strobilanthes cusia (Ness) W. Ktze.*stem and leavesEtOAcNANTSCW091101179*Thlaspi arvense L.*whole plantMeOHNANTTAL091103180*Thlaspi arvense L.*whole plantEtOAcNANTTAL091103181*Turczaninovia fastigiata (Fisch.) DC.*flowersMeOHNANTTFD091101182*Turczaninovia fastigiata (Fisch.) DC.*flowersEtOAcNANTTFD091101183*Vitex trifolia L.*stem and leavesEtOAcNANTVTL091103184*Vitex trifolia L.*stem and leavesMeOHNANTVTL091103185*Wikstroemia indica (Linn.) C. A. Mey.*whole plantMeOHNANTWIC091103186*Wikstroemia indica (Linn.) C. A. Mey.*whole plantEtOAcNANTWIC091103187*Xanthium sibiricum Patrin ex Widder*fruitEtOAcNANTXSP091103188*Xanthium sibiricum Patrin ex Widder*fruitMeOHNANTXSP091103189*Zanthoxylum nitidum (Roxb.) DC.*rootMeOHNANTZND091101190*Zanthoxylum nitidum (Roxb.) DC.*rootEtOAcNANTZND091101^a^Percentage inhibition was calculated relative to a blank group containing virus NA but no inhibitors, final concentration at 40 μg/mL; ^b^IC~50~ values represent the concentration that caused 50% NA enzyme activity loss, the average of at least three independent assays, IC~50~ values are in μg/mL. ^c^: not active; ^d^: not test

To validate whether these extracts **1**--**5** that exhibited NA inhibitory activity could protect host cells from influenza virus A (H1N1) infections, the CPE reduction assay was carried out in MDCK cells. The human influenza virus A/PR/8/34 (H1N1) strain was used to infect MDCK cells. Cells were incubated in the presence or absence of the extracts **1--5**, after 48 h of incubation, their CPE reduction activity on virus multiplication was then examined. As shown in Table [2](#Tab2){ref-type="table"}, the extracts **1--5** could protect MDCK cells from the infection of influenza virus A (H1N1), exhibited a drastic reduction of influenza virus-induced CPE. The EC~50~ values of the extracts **1**--**5** ranged from 1.8 to 14.1 μg/mL, similar to the results obtained in NA assays. Among the five extracts, the MeOH extract (**2)** from the fruits of *Amomurn villosum* had excellent CPE activity with very low EC~50~ values of 1.8 μg/mL, this is comparable to that of the positive compound ribavirin (3.2 μg/mL). The viability of MDCK cells incubated in the presence or absence of the extracts was evaluated by MTT assay, the CC~50~ values of the extracts **1**--**5** was found to be from 97.0 to 779.2 μg/mL, suggesting that the extracts protected significantly host cells from influenza virus infection and did not exhibit considerable cytotoxicity against MDCK cells. The maximal non-cytotoxic concentration (MNCC) of the extracts **1--5** were found to be from 30 to 300 μg/mL in MDCK cells. Their therapeutic selective index (SI) in MDCK cells ranged from 14 to 438, and among of them, the SI value of *A. villosum* was highest on basis of its low cytotoxicity and its high CPE effect. These data demonstrated that the extracts **1--5** protected MDCK host cells from viral damage with very low toxicity. Thus, in agreement with that these extracts inhibited NA activities, the extracts **1**--**5** reduced host cell damage caused by the influenza virus A (H1N1) infection.Table 2Inhibitory activity of Chinese herbs extracts (**1**--**5**) on A(H1N1) influenza virus by CPE assaySample No.EC~50~^a^CC~50~^b^MNCC^c^SI^d^17.7184.3302421.8779.230043838.1478.41005947.297.03014514.1744.330053Ribavirin3.2\> 100---^e^\> 31Zanamivir\> 90.4\> 1506.0\> 301.217^a^EC~50~: Effective concentration required to protect 50% of cells; ^b^ CC~50~: Median (50%) cytotoxic concentration in MDCK cells; ^c^ MNCC: Maximal non-cytotoxic concentration in MDCK cells, values in μg/mL; ^d^ SI:Selectivity index, CC~50~/EC~50~.^e^: not test

To further examine whether the protective effect of the extracts**1**--**5** is related with the inhibition of influenza viral replication, total RNA was extracted and subjected to quantitative reverse-transcription PCR in the A/H1N1 virus-infected A549 cells. Our results showed that treatment with the extracts **1**--**5** for 5 h resulted in a substantial reduction in viral RNA expression level in a dose-dependent manner (Fig. [1](#Fig1){ref-type="fig"}). All extracts **1**--**5** at the high concentration (30 μg/mL) had significant inhibitory effects on viral RNA expression as compared with untreated control, even more powerful than ribavirin (Fig. [1](#Fig1){ref-type="fig"}). The extracts **2**--**5** at medium concentration (10 μg/mL) also demonstrated significant inhibitory effects on viral RNA synthesis. Interestingly, the extracts **3** and **4** at low concentration of 3 μg/mL still significantly inhibited RNA synthesis of influenza viruses. These data indicate that the extracts **1**--**5** could inhibit significantly the replication of influenza viruses in cultures by RT-PCR analysis, which validated their anti-influenza viral activity obtained by CPE reduction assay.Fig. 1Dose-dependent inhibitory effect of the extracts **1**--**5** on viral RNA synthesis. A549 cells were infected with 100 TCID~50~ influenza H1N1 viruses and treated with different concentrations of the extracts **1**--**5** (3, 10 or 30 μg/mL) and the DMSO (0.03%) for 5 h. The total RNA was extracted and followed by qPCR analysis. To quantify the changes in gene expression, the 2^-ΔΔC(q)^ method was used to calculate relative changes which were normalized to the GAPDH gene and the untreated control (model group, which was set to 1). Value calculated as Mean ± SD of three independent tests, with ^\*^ *p* \< 0.05 and ^\*\*^*p* \< 0.001, respectively

Discussion {#Sec12}
==========

In the course of our screening of NA inhibitors for influenza virus A (H1N1), a total of 190 extracts of 95 medicinal plants traditionally used in Lingnan Chinese Medicines were submitted to in vitro screening for their NA inhibitory activities. Among of them, the organic extracts **1**--**5**, obtained from *Melaphis chinensis*, *Amomurn villosum*, *Sanguisorba officinalis* and *Flos Caryophylli*, were found to significantly inhibit the NA activity (IC~50~ \< 10 μg/mL, Table [1](#Tab1){ref-type="table"}) and the replication of influenza virus in a dose-dependent manner (Fig. [1](#Fig1){ref-type="fig"}), and exhibited very low cytotoxicity to the host cells with the high selective index (SI) values ranging 14 to 438 (Table [2](#Tab2){ref-type="table"}). Therefore, these Chinese herb extracts might contain bioactive components responsible for anti-influenza virus activity at non-toxic concentration and they could be a promising source of natural NA inhibitors.

It was demonstrated previously that the aqueous extracts of barks, leaves and galls of *Melaphis chinensis* have anti-influenza virus activity and some compounds such as gallotannins isolated from *M. chinensis* are responsible for the anti-influenza virus effect \[[@CR17]\]. The presence of such compounds in our EtOAc and MeOH extracts of galls of *M. chinensis* may explain the biological activities seen in our screenings*.*

*Flos Caryophylli* also known as cloves, is considered acrid, warm and aromatic in Traditional Chinese Medicines for the treatment of stomachache, diarrhea and dental pain \[[@CR18]\]. It was reported that the hot water extract of *Flos Caryophylli* have been shown to have anti-herpes virus, anti-hepatitis C virus and anti-cytomegalovirus activities in vitro and in vivo, and compounds such as ellagitannin and eugeniin were identified as the bioactive components with anti-virus properties \[[@CR19]\]. In the present study, the MeOH extract of *Flos Caryophylli* showed IC~50~ value of 9.1 μg/mL towards NA and EC~50~ value of 14.1 μg/mL against influenza virus. In our latest phytochemical study on the MeOH extract of *Flos Caryophylli* \[[@CR14]\], a bioassay-guided isolation led to identification of ten flavonoids, seven tannins and two chromones as NA inhibitors with IC~50~ values ranging from 8.4 to 94.1 μM. These polyphenolic constituents were found to protect MDCK cells from A(H1N1) influenza infections (EC~50~ = 1.5--84.7 μM) with very low cytotoxicity to the host cells (CC~50~ = 374.3--1266.9 μM)), with selective index (SI) ranging from 7 to 297 \[[@CR14]\].

The roots of *S. officinalis* (Rosaceae) are well-known Chinese herbs officially listed in the Chinese Pharmacopeia and have been used for the treatment of bleeding, diarrhea and burns. Early chemical studies showed that *S. officinalis* synthesize a variety of secondary metabolites, particularly polyphenols, triterpenoids, saponins and flavonoids with specific biological activities such as anti-asthmatic, anti-bacterial, anti-cancer and anti-inflammation \[[@CR20]--[@CR25]\]. A variety of flavonoids, saponins and polyphenols isolated from medicinal plant have been studied extensively and exhibited anti-influenza activities \[[@CR12]\]. The MeOH extract of *S. officinalis* showed strong activities towards NA (IC~50~: 5.1 μg/mL) and against influenza virus (EC~50~: 8.1 μg/mL). The anti-influenza activity may be due to the presence of flavonoids and polyphenols in the MeOH fraction.

The fruits of *A. villosum* (Zingiberaceae) were consumed widely as popular cooking spices in East Asian countries and have been traditionally used as a medicine to treat various digestive disorders \[[@CR26]\]. The volatile oils of the fruits of *A. villosum* were shown to be the major components and suggested to be responsible for the different biological activities such as analgesic, anti-oxidation and anti-inflammation \[[@CR27]\]. In this study, the MeOH extract of the fruits of *A. villosum*was shown to significantly inhibit NA activities (IC~50~: 4.9 μg/mL) and protect the host cells from CPE damage (EC~50~: 1.8 μg/mL) without cytotoxicity, and its therapeutic selective index (SI) is 439 in MDCK cell culture.

In this study, we limit our study on EtOAc and MeOH extracts of medical plants since bioassay-guided isolation of neuraminidase inhibitors in aqueous extracts remains a challenging task for us. However, this may decrease the risk of false-positive results in the enzyme-based screening caused by some interfering components present within aqueous extracts. Future study will try to improve the screening methods on aqueous extracts that may also contain active components with anti-neuraminidase activity.

Conclusion {#Sec13}
==========

We carried out the in vitro screening of anti-neuraminidase activity of 190 herbal extracts from 95 medicinal plants traditionally used in Lingnan Chinese Medicines. Among the tested extracts, 5 extracts, obtained from *Amomurn villosum*, *Melaphis chinensis*, *Sanguisorba officinalis* and *Flos Caryophylli*, showed potent NA inhibitory activity. Comprehensive literature survey revealed that no study has been reported on the effects of the organic extracts of *A. villosum* and *S. officinalis* on anti-influenza virus activities and small-molecule NA inhibitors from these extracts have not been chemically identified yet. Further studies are underway to isolate bioactive components of these extracts by bioassay-guided fractionation, and to explore their antiviral mechanisms and finally determine their clinical potentials.

CPE

:   Cytopathic effect

HA

:   Haemagglutinin

HHDP

:   Hexahydroxydiphenoyl

MDCK

:   Madin-Darby canine kidney

MNCC

:   Maximal non-cytotoxic concentration

MTT

:   3-\[4,5-dimethyl-thiazol-2-yl\]-2,5- diphenyl tetrazolium bromide

MUNANA

:   methylumbelliferyl-α-D-N-acetylneuraminate

NA

:   Neuraminidase

SI

:   Selectivity index.

The authors would like to acknowledge all the fellows in Research Center of Medicinal Plants Resource Science and Engineering, Guangzhou University of Chinese Medicine for their great support and encouragement. We also thanks for their assistance in collecting medicinal plants from Jinxing Qiu, Guozheng He and Honghui Huang.

Funding {#FPar1}
=======

This work was supported by China National Natural Science Foundation Grant (No.81373432), Guangzhou Science and Technology Program Grant (No. 2014 J4100118) to JL, National Great Science and Technology Major Projects (2012ZX09301002-2013HXW-11) and Beijing Natural Science Foundation Grant (No. 7152103) to AL.

Availability of data and materials {#FPar2}
==================================

The data sets used and /or analysed during the current study available from the corresponding authors on reasonable request.

JL and AL conceived and designed the study. JL, KC and HM collected the herbs and prepared the herbal extracts. MZ, LG, WZ and AL carried out herbal screening and anti-influenza virus studies. JL, MZ and AL analyzed data. JL wrote the manuscript. All authors read and approved the final manuscript.

Ethics approval and consent to participate {#FPar3}
==========================================

Not applicable.

Consent for publication {#FPar4}
=======================

Not applicable.

Competing interests {#FPar5}
===================

The authors declare that they have no competing interests.

Publisher's Note {#FPar6}
================

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
